Bioglan's shares plunge on wider 1st-half loss

Article Abstract:

Bioglan Pharma PLC saw its share value drop 85% after the firm posted a higher loss for the 2001 first-half. Bioglan posted a 35.72 million pounds pretax loss for the period, compared to 746,000 pounds during the same 2000 period.

Sales, profits & dividends, Pharmaceutical preparations, Securities prices, Drugs, Finance, Prices and rates, Securities, Bioglan Pharma PLC

---

Acambis lands contract with U.S. government

Article Abstract:

Acambis PLC has received a contract from the U.S. government to make vaccines for a possible biological attack by terrorists. The contract is valued at $343 million (372.2 million euros).

New orders received, Biological products exc. diagnostic, Vaccines for Human Use, Prevention, Contracts, Biological warfare, Vaccines industry, Biological products industry, Vaccines, Terrorism, Acambis PLC

---

Smith & Nephew ends battle for Centerpulse

Article Abstract:

Smith and Nephew PLC have withdrawn from the acquisition bidding for Centerpulse AG. Smith and Nephew could not outbid Zimmer Inc. for Centerpulse.

Strategy & planning, Acquisitions & mergers, Switzerland, Planning, Mergers, acquisitions and divestments, Company acquisition/merger, Medical equipment and supplies industry, Medical equipment industry, Company business planning, Smith & Nephew PLC, Centerpulse AG, Zimmer Inc.

Similar abstracts:

• Abstracts: Olivetti, Mannesmann are mum on suit. Seat board extends its offer for Eniro to at least June 27. Cecchi Gori to buy rights to MTV in Italy via Beta
• Abstracts: SkyePharma's loss widened in first half. Oxford loss widened in half. Shire's earnings rise 66%, topping estimates
• Abstracts: UK's Sun Life posts strong sales for the first half. Friends Provident posts results for first half. Britannic to cut 2,000 jobs amid tough industry climate
• Abstracts: Verbund's earnings improve. RWE's net rose 22% in 1st quarter, reflecting resilience
• Abstracts: TF1's net declines 4.3% on advertising slump. Ingenico halves group net

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.